New Agreement to optimise oncology combination with top five pharma company

New Agreement to optimise oncology combination with top five pharma company

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a new agreement with a top five pharma company.  Under the agreement, Physiomics will determine the optimal dosing and timing of a combination of two compounds currently under development by this new customer… read more